St. Jude acquires remaining shares of CardioMEMS for $375M

  • by: Steve Alexander , Star Tribune
  • Updated: May 28, 2014 - 4:16 PM

The deal follows CardioMEMS’ product receiving regulatory approval for a sensor that is implanted in the pulmonary artery.

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

Advertisement
Golden Gavel by Star Tribune

Countdown to great deals

Bid Sept. 21-29

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT